Rapid tests are essential tools to help diagnose what’s behind your symptoms, so you can treat earlier and get well sooner.
There’s rarely a convenient time to take a medical test. The good news is, you no longer need to go out of your way to get fast, simple, and more accessible testing. From corner pharmacies to local urgent care clinics, our rapid test products are widely available. The same testing technology that is used in doctor's offices & emergency rooms is now also available in convenient care locations. Rapid tests are essential tools in helping to reduce the spread because they quickly identify respiratory infections.
The BinaxNOW™ rapid antigen tests employ the same technology used by doctors and healthcare professionals—bringing the most widely available rapid COVID-19 tests to more people and places.
Discover the fast, proven and trusted COVID-19 antigen test that is readily available over-the-counter at retailers and pharmacies across the country. BinaxNOW™ COVID-19 Antigen Self Test is a simple solution for COVID-19 infection detection. Detects multiple strains, including Delta and Omicron variants.*
This easy-to-use self-test provides quick results in 15 minutes. Capture your results with optional self-reporting only (does not provide a verified result). If you are interested in a verified result for travel, please see the BinaxNOWTM COVID-19 Ag Card Home Test below.
For personal use only.
At-home, our virtually guided COVID-19 antigen test provides rapid and verifiable results in the safety and convenience of your home. An online certified health guide walks you through the testing process via video call and you receive verified results sent to you on the complementary NAVICATM app.
The complementary NAVICA™ mobile app enables the testing process and displays BinaxNOW COVID-19 test results that are shareable for travel or at workplaces, organizations, or events that require proof of test for entry. Join an eMed session for live testing support with a certified guide today.
ID NOW™ rapid molecular testing is significantly faster than other molecular methods and more accurate than conventional rapid tests.1-4
Used widely by urgent care clinics, pharmacies, doctor's offices, and hospitals, ID NOW is a fast, convenient, and proven way to test for respiratory infections.
This rapid molecular instrument provides your healthcare professional with timely results, that inform your treatment, which may include antivirals or antibiotics, so you can get well sooner. Available tests include: Influenza (Flu), Strep A, COVID-19, and RSV
Testing has now become part of our daily conversation due to the COVID-19 pandemic. There are many different types of respiratory diagnostic tests, and it can be hard to keep track of what each test does and when and where it's used.
When a virus enters your body, it starts multiplying, and you may or may not have symptoms.
As the virus multiplies, the body begins to react to the viral antigens, possibly resulting in symptoms.
As your body starts to fight off infection, your immune system produces IgM and IgG antibodies.
Rapid molecular tests detect viral RNA or DNA. They are performed via a nasal or throat swab and provide results in less than 15 minutes. These tests are used at the point of care in doctors offices, urgent care, emergency departments, and pharmacies.
Molecular PCR tests are performed via a nasal, nasopharyngeal or throat swab which is usually sent to a lab or hospital to run on a larger instrument together with higher volumes of patient samples. Results are typically available in 1-3 days
Rapid antigen tests are also performed via nasal or throat swab with results in less than 15 minutes. These tests can either be used at doctors' offices, urgent care, emergency rooms, pharmacy clinics, or bought at retailers for self-testing
When you or someone you care about is sick and you seek treatment, a test is often used to figure out what is going in inside of you. Learn about respiratory illnesses and the newer advanced test technology that offers faster time to test results. Knowing now means you’ll be treated earlier which can help you get well sooner.
Find out more about how rapid molecular testing works with our Patient Learning Series (PALS).
Learn about why you need a COVID-19 test and the types of COVID-19 tests, including the different types of molecular tests.
COVID isn't the flu. Here's what you need to know and how testing can help you know what you're treating.
*Abbott conducted a computational analysis of the detection of multiple SARS-COV-2 Strains, including the Delta and Omicron variants, and predicts no impact to the performance of our BinaxNOW™ COVID-19 Antigen Self Test.
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb 3(b)(1), unless the declaration is terminated or authorization is revoked soon. For serial testing, the BinaxNOW COVID-19 Antigen Self-Test should be performed twice over 3 days, at least 24 hours (and no more than 48 hours) apart. For symptomatic use, a single test can be used.
The ID NOW COVID-19 product has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization (EUA) for use by authorized laboratories and patient care settings. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Based on your current location, the content on this page may not be relevant for your country.
